Table 5 |
|||
| Odds ratios of immunohistochemical markers | |||
| Odds ratio | 95% confidence interval | Significance | |
| For differentiation of borderline and malignant tumorsa | |||
| p53* | 2.1 | 1.2-3.8 | p < 0.05 |
| For differentiation of benign and borderline and malignant tumors combinedb | |||
| p21* | 1.7 | 1.0-2.8 | P < 0.05 |
| bax** | 2.0 | 1.0-3.9 | P < 0.05 |
| Metallothionein** | 1.5 | 1.1-1.9 | p < 0.05 |
*Nuclear staining score. **Quick score.
aOnly p53 was determined the significant predictor for malignant tumors during differentiation between borderline and malignant tumors.
bp21, bax, and metallothionein was determined the significant predictors for borderline and malignant tumors combined during differentiation between benign and borderline and malignant tumors combined.
Ozer et al. Diagnostic Pathology 2012 7:124 doi:10.1186/1746-1596-7-124
